(Q51614386)

English

Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.

scientific article published in September 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

Prelević GM

1

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

Würzburger MI

2

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

Trpković D

3

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

Balint-Perić L

4

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

publication date

1 September 1990

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

Gynecological Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

4

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

3

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

157-168

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513599009009803

21 January 2018

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.3109%2F09513599009009803

21 January 2018

Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513599009009803

21 January 2018

Immunochemical quantitation of antigens by single radial immunodiffusion

1 reference

https://api.crossref.org/works/10.3109%2F09513599009009803

21 January 2018

Analysis of serial measurements in medical research

1 reference

https://api.crossref.org/works/10.3109%2F09513599009009803

21 January 2018

Paradoxical effects of the anti-androgen cyproterone acetate on lipid and lipoprotein metabolism.

1 reference

https://api.crossref.org/works/10.3109%2F09513599009009803

21 January 2018

The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism.

1 reference

https://api.crossref.org/works/10.3109%2F09513599009009803

21 January 2018

Identifiers

10.3109/09513599009009803

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/2284980

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51614386&oldid=1588419286"